ArticleMolecular therapy. Methods & clinical development2020

CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich's Ataxia.

Celine J Rocca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.